Doing Business In Japan

ima logo

News 37

Japanese deal for BioFocus

BioFocus, based at the heart of the Cambridge UK science & technology cluster, is partnering Japanese pharmaceutical giant Ono in a drug discovery programme targeting disorders of the Central nervous system (CNS).

The Chesterford Research Park company - Galapagos' service division - has signed a new alliance agreement with Ono Pharmaceutical Co., Ltd. of Osaka.

BioFocus will use its drug discovery platform to deliver leads and clinical candidates for its client. Financial details of the collaboration were undisclosed.

Dr Chris Newton, SVP Galapagos Services and managing director of BioFocus said: "We are delighted to have this new agreement, which is the first drug discovery program with this, a most valued, client.

"This project plays to BioFocus' historic strengths and the expanding breadth and depth of this partnership is testament to a tried and trusted relationship

To continue reading this article click here


Source -


Partner Profiles